Urolog. pro Praxi, 2005; 5: 196-199

NOSOCOMIAL URINARY TRACT INFECTIONS, MICROBIOLOGY DIAGNOSTICS AND TERAPEUTIC APPROACH

doc. MUDr. Milan Kolář PhD1, MUDr. Jindra Lochmannová jr2, doc. MUDr. Dagmar Koukalová CSc1, MUDr. Yvona Lovečková1
1 Ústav mikrobiologie FN a LF UP v Olomouci
2 Interní klinika fakultní nemocnice Motol a 2. lékařské fakulty Univerzity Karlovy v Praze

One of the most important adverse effects of antibiotics is the increasing resistance of bacteria to their activity. Rational antibiotic therapy is therefore an integral part of preventing bacterial resistance from developing. Nosocomial urinary tract infections are caused by numerous bacterial species, often with higher levels of resistance to antimicrobial agents. Aminopenicillins or aminopenicillins with inhibitors of bacterial ß-lactamases combined with aminoglycosides can be used as drugs of first choice. However, it must be stressed that the regimens of initial antibiotic therapy are strongly influenced by local conditions reflected by the results of local bacterial surveillance.

Keywords: Key words: nosocomial urinary infections, antibiotic therapy.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolář M, Lochmannová J, Koukalová D, Lovečková Y. NOSOCOMIAL URINARY TRACT INFECTIONS, MICROBIOLOGY DIAGNOSTICS AND TERAPEUTIC APPROACH. Urol. praxi. 2005;6(5):196-199.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the national nosocomial resistance surveillance group. Diag Microbiol Dis 1992; 15: 37-42. Go to original source...
    2. Bartoníčková K. Léčba močových infekcí. Urol pro prax 2004; 6: 251-254.
    3. Černohorská L, Votava M. Biofilmy a jejich význam v lékařské mikrobiologii. Epidemiol Mikrobiol Imunol 2002; 51: 161-164.
    4. Duben J, Hausner O. Vyšetření při bakteriálních onemocněních. Avicenum 1986; 178 s.
    5. Johnson CC. Definitions, classification and clinical presentation of urinary tract infection. Med Clin North Am 1991; 75: 241-252. Go to original source... Go to PubMed...
    6. Kolář M. Antibiotická léčba nozokomiálních infekcí. Triton 2000; 177 s.
    7. Kolář M, Heinigeová B, Bartoníková N, Čermák P, a kol. Grampozitivní patogeny při infekcích krevního řečiště - multicentrická studie. Klin Mikrobiol Inf Lék 2003; 9: 244-252.
    8. Kolář M, Urbánek K, Látal T. Antibiotic selection pressure and development of bacterial resistance. Intern J Antimicrob Agents 2001; 17: 357-363. Go to original source... Go to PubMed...
    9. Lochmann O. Stručný průvodce léčbou antibiotiky a chemoterapeutiky. BMS - Praha 1998; 234 s.
    10. Lochmannová J, Kolář M, Urbánek K, Koukalová D. Antibiotická léčba bakteriálních infekcí z pohledu klinika, mikrobiologa a farmakologa. Int Med Prax 2004; 6: 15-20.
    11. Medeiros AA. Evolution and dissemination of ß-lactamases accelerated by generations of ß-lactam antibiotics. Clin Inf Dis 1997; 24: 19-45. Go to original source... Go to PubMed...
    12. Neu HC. The crisis of antibiotic resistance. Science 1992; 257: 1064-1072. Go to original source... Go to PubMed...
    13. Reese RE, Betts RF. A practical approach to infectious diseases. Fourth Edition. Little, Brown and Company 1996; 1461 s.
    14. Simon C, Stille W. Antibiotika v současné lékařské praxi. Grada 1998; 711 s.
    15. Teplan V, Horáčková M, Bébrová E, Janda J, a kol. Infekce ledvin a močových cest v dospělém a dětském věku. Grada Publishing 2004; 252 s.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.